Physician profile
Michael E Lewis
NPI 1215929682
$2,721.62
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,944 · 2020: $487 · 2021: $164 · 2022: $64.56 · 2023: $23.40 · 2024: $39.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $62.63.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $62.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $505.33 | 2019-2022 | |
| Amgen INC. | $478.16 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $328.09 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $321.71 | 2019-2020 | |
| Pfizer INC. | $313.57 | 2019-2021 | |
| Philips North America LLC | $182.85 | 2020-2024 | (Cm9) Amb Mon & Diag Und |
| Astellas Pharma US INC | $133.46 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $67.44 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $60.52 | 2019 | |
| Amarin Pharma, INC. | $52.68 | 2019-2020 | |
| Medtronic Vascular, INC. | $44.95 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $32.51 | 2019 | |
| Boston Scientific Corporation | $24.82 | 2022 | |
| Bausch & Lomb Americas INC. | $23.40 | 2023 | Xiidra |
| Alnylam Pharmaceuticals INC. | $21.29 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $20.52 | 2019 | |
| Medtronic, INC. | $20.35 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.29 | 2020 | |
| Akcea Therapeutics, INC. | $16.36 | 2020 | |
| Sanofi-Aventis U.S. LLC | $16.11 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.15 | 2019 | |
| Merck Sharp & Dohme LLC | $12.25 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $10.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.